New research described a cellular mechanism behind pancreatic cancer-associated cachexia, highlighting crosstalk between distinct pancreatic cancer subpopulations, macrophages, and fibroblasts. The work suggests potential biomarker angles for wasting, a complication that often drives morbidity and limits treatment tolerance. For translational teams, the findings add mechanistic support to multi-cell-type models of cachexia and point toward targets that sit beyond tumor cells alone.